On the books

Photo by Robert BostonMissouri Gov. Matt Blunt signed Senate Bill 567, which requires health insurers to cover primary health-care costs for patients involved in approved phase II clinical trials for cancer.

New diabetes drug may have welcome side effect: weight loss

WellingThe Washington University Diabetes Center at Barnes-Jewish Hospital focuses on providing patients with the latest technology, treatments and clinical research. Some patients at the center are receiving a new diabetes drug that may give a welcome side effect — weight loss. Research lab supervisor Cris Welling began taking Byetta about 10 months ago and has lost 40 pounds.

Tumor wizardry wards off attacks from the immune system

Like the fictional wizard Harry Potter, some cancerous tumors seem capable of wrapping themselves in an invisibility cloak. Researchers at the School of Medicine have found that pancreatic tumors hide from the body’s immune surveillance by surrounding themselves with cells that make it hard for the immune system to detect them.
View More Stories